20 / 25
Page 84
conferenceseries
.com
Volume 8
Journal of Gastrointestinal & Digestive System
ISSN: 2161-069X
Bariatric Surgery 2018 & Gastro 2018
March 15-16, 2018
JOINT EVENT
12
th
Global Gastroenterologists Meeting
3
rd
International Conference on Metabolic and Bariatric Surgery
&
March 15-16, 2018 Barcelona, Spain
Prevelance of occult HBV in chronic hepatitis C and cryptogenic hepatitis patients
Cakal B
Istanbul University, Turkey
O
ccult Hepatitis B Virus (HBV) infection (OBI) is considered as the possible phase of the HBV natural history but the
molecular mechanisms and clinical impact and epidemiological aspect of OBİ still remains unclear. We investigated
the prevalence of OBI and its clinical impact among patients with Hepatitis C virus (HCV) infection and with cryptogenic
hepatitis. This study protocol was approved by the ethics committee of İstanbul University İstanbul School of Medicine (No:
2015/1519). This prospective cohort study included a total of 60 HBsAg-negative patients (27 patients with chronic HCV and
33 patients with cryptogenic hepatitis) were enrolled in the Department of Gastroenterology, Istanbul Faculty of Medicine.
Liver tissue samples had been obtained by percutaneous needle liver biopsy and immediately frozen and stored at -80°C. Total
nucleic acids were extracted from frozen liver biopsies using QIAamp DNA Mini Kit (Qiagen) according to the manufacturer’s
instructions. OBI was defined as HBV DNA positivity in 2 or more different viral genomic regions by nested polymerase
chain reaction PCR using 4 sets of primers in preS-S (S), precore-core (C), Pol, and X viral regions of the HBV genome.
Plasmid HBV DNA 4.1 kb and liver biopsy samples obtained from patients with chronic HBV infection (positive control) were
used. Statistical analyses were evaluated using Mann–Whitney U test, Chi-square test and Kruskal Wallis tests. The baseline
characteristics of patients are presented in Table 1. The prevalence of OBI was 25.9% (7/26) with 27.3% (9/33), 26.7% (16/60)
in patients anti-HCV (+), cryptogenic hepatitis, and totaly respectively. There wasn’t significant differences for prevelance of
OBİ between patients with Chronic HCV infection and cryptogenic hepatitis (P=0.907). Patients with anti-HCV (+), OBİ
(+) were older compared with patients anti-HCV (+), OBİ (-), (P: 0.033). As it is expected that cryptogenic hepatitis patients
had higher serum alkaline phosphatase and gamma-glutamyltransferase level (P<0.05). Clinical signifance and role of OBI in
patients with chronic HCV infection is controversial. Accordingly, first results of the study of prevelance of OBİ is correlated
with endemicity of Hepatitis B infection. Moreover, OBİ can be associated with liver injury rather than chronic HCV infection.
Therefore, it appears that host factors rather than viral factors are more responsible for OBI.
bulentcakal@yahoo.comJ Gastrointest Dig Syst 2018, Volume 8
DOI: 10.4172/2161-069X-C1-065